New ANZCCM president sets sights on ‘shaping the future of cannabinoid medicine’ by Steve Jones June 16, 2026June 16, 2026 Harm reduction specialist Dr Davin Gunn has been elected president of the Australian and New Zealand […]
Lancet clinical review paper: why absence of evidence is not evidence of absence by Andrew Proudfoot March 18, 2026March 18, 2026
Defending the role of cannabis as a public and community good: the call to action in 2025 by Andrew Proudfoot January 9, 2025January 9, 2025
